What are the social effects of the new migraine treatment?
Migraines affect many people of working age and the social impact beyond the health service is considerable. Migraines involve acute attacks with bursting headaches and the condition has significant effects on patients’ quality of life.
Aimovig is a drug indicated for the prevention of migraine in adults who experience at least four migraine days per month. On behalf of the pharmaceutical company Novartis, Oslo Economics has analyzed the impact on the health service and society as a result of introducing the new drug to the market.